A Brief Description of Different Types of Cancers and Role of Some Herbs & Bioactive Compounds in Lung Cancer Management

Roshan Kumar; Prachi Sood; Rahaman Shaik; Harjeet Kumar Singh; Ayush Verma

doi:10.55544/jrasb.2.4.5

Authors

Roshan Kumar Assistant Professor, Department of Pharmacology, Guru Nanak College of Pharmaceutical Sciences, Dehradun, INDIA.
Prachi Sood Assistant Professor, Department of Pharmacy, Guru Nanak College of Pharmaceutical Sciences, Dehradun, INDIA.
Rahaman Shaik PhD Scholar, Department of Pharmacology, SPER, Jamia Hamdard, New Delhi, INDIA. https://orcid.org/0000-0002-6084-6257
Harjeet Kumar Singh Department of Pharmacy, Guru Nanak College of Pharmaceutical Sciences, Dehradun, INDIA.
Ayush Verma Assistant Professor, Department of Pharmacology, Quantum University, Roorkee, Uttarakhand, INDIA.

DOI:

https://doi.org/10.55544/jrasb.2.4.5

Keywords:

Cancer, Lung cancer, Bioactive compounds, Herbs

Abstract

Cancer immunotherapy has considerably raised patient survival rates and significantly improved patients' quality of life in comparison to the gold standard of care, which includes chemotherapy, radiation therapy, and surgery. Immunotherapy has firmly established itself as a novel pillar of cancer care across the board, from the metastatic stage all the way through adjuvant and neoadjuvant treatment in a wide variety of cancer types. In this overview, the primary emphasis will be placed on the seminal moments in the history of cancer immunotherapy that prepared the way for the cutting-edge treatments that are available today. Cancer treatment that makes use of medicinal herbs and the phytocompounds that can be obtained from those herbs is becoming an increasingly attractive option. It has been demonstrated in a number of clinical studies that the use of herbal medicines in conjunction with conventional therapy can increase survival rates, immunological modulation, and quality of life (QOL) in patients who have cancer. In addition to this, we highlight the challenges and restrictions currently faced by cancer checkpoint immunotherapy as well as the cutting-edge research being conducted in the fields of individualized cancer vaccines, autoimmunity, the microbiome, the microenvironment of tumors, and metabolomics to find solutions to these problems. For hundreds of years, practitioners of traditional medicine have depended on treatments derived from plants. Many studies on their use have been carried out all over the world, and some of the findings have led to the development of medicines that are derived from plants. The global market for medicinal plant products is estimated to be worth more than one hundred billion dollars each year. This research investigates the role, contributions, and utility of medicinal plants in the context of the current strategic methods to disease prevention, notably lung cancer, which is a public health concern. The focus of this research is on the current strategic approaches to disease prevention.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. cell, 100(1), 57-70.

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. cell, 144(5), 646-674.

Fearon, E. R., & Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. cell, 61(5), 759-767.

Vogelstein, B., & Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nature medicine, 10(8), 789-799.

Sarkar, S., Goldgar, S., Byler, S., Rosenthal, S., & Heerboth, S. (2013). Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy. Epigenomics, 5(1), 87-94.

Einav Nili, G. Y., Saito, Y., Egger, G., & Jones, P. A. (2008). Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med., 59, 267-280.

Bird, A. P. (1986). CpG-rich islands and the function of DNA methylation. Nature, 321(6067), 209-213.

Kim, J. J., & Tannock, I. F. (2005). Repopulation of cancer cells during therapy: an important cause of treatment failure. Nature Reviews Cancer, 5(7), 516-525.

Bernier, J. EJ Hall A. Giaccia. 2004. Radiation oncology: a century of achievements. Nat. Rev. Cancer, 4, 737-747.

Harada, H. (2011). How can we overcome tumor hypoxia in radiation therapy?. Journal of radiation research, 52(5), 545-556.

Huang, L., Snyder, A. R., & Morgan, W. F. (2003). Radiation-induced genomic instability and its implications for radiation carcinogenesis. Oncogene, 22(37), 5848-5854.

Wild-Bode, C., Weller, M., Rimner, A., Dichgans, J., & Wick, W. (2001). Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer research, 61(6), 2744-2750.

Karger, C. P., & Jäkel, O. (2007). Aktueller Stand und neue Entwicklungen in der Ionentherapie. Strahlentherapie und Onkologie, 183, 295-300.

Kalia, M. (2015). Biomarkers for personalized oncology: recent advances and future challenges. Metabolism, 64(3), S16-S21.

Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., ... & Bray, F. (2020). Global cancer observatory: cancer today. International Agency for Research on Cancer. Lyon, France.

Rao, H. L., Chen, J. W., Li, M., Xiao, Y. B., Fu, J., Zeng, Y. X., ... & Xie, D. (2012). Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PloS one, 7(1), e30806.

Ferlay, J., Bray, F., Pisani, P., & Parkin, D. M. (2004). GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base, (5).

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2020). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018). Ca-a Cancer Journal for Clinicians, 70(4), 313-313.

Jacques Ferlay, I. S., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., ... & Bray, F. (2014). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 29.

Piñeros, M., Sierra, M. S., & Forman, D. (2016). Etiology of lung cancer (C33–34) in Central and South America. Lyon: International Agency for Research on Cancer, 8.

Patricia, M. (2018). de Groot, Carol C. Wu, Brett W. Carter RFM. The epidemiology of lung cancer. Transl Lung Cancer Res, 1982(7), 272-84.

de Groot, P., & Munden, R. F. (2012). Lung cancer epidemiology, risk factors, and prevention. Radiologic Clinics, 50(5), 863-876.

Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013). Epidemiology of lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143(5), e1S-e29S.

Loprieno, N. (1975). International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risk of chemicals to man:" relevance of data on mutagenicity". Mutation research, 31(3), 210.

Malhotra, J., Malvezzi, M., Negri, E., La Vecchia, C., & Boffetta, P. (2016). Risk factors for lung cancer worldwide. European Respiratory Journal, 48(3), 889-902.

Bray, F. F. J. S., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. J. C. C. J. C. (2020). Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin, 70(4), 313.

Farinha, P., Pinho, J. O., Matias, M., & Gaspar, M. M. (2021). Nanomedicines in the treatment of colon cancer: A focus on metallodrugs. Drug Delivery and Translational Research, 1-18.

Gurba, A., Taciak, P., Sacharczuk, M., Młynarczuk-Biały, I., Bujalska-Zadrożny, M., & Fichna, J. (2022). Gold (III) derivatives in colon cancer treatment. International Journal of Molecular Sciences, 23(2), 724.

Almutairi, M. H., Alrubie, T. M., Alamri, A. M., Almutairi, B. O., Alrefaei, A. F., Arafah, M. M., ... & Semlali, A. (2022). Cancer-Testis Gene Biomarkers discovered in Colon Cancer Patients. Genes 2022, 13, 807.

Zauber, A. G., Winawer, S. J., O'Brien, M. J., Lansdorp-Vogelaar, I., van Ballegooijen, M., Hankey, B. F., ... & Waye, J. D. (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med, 366, 687-696.

Winawer, S. J., Zauber, A. G., Ho, M. N., O'brien, M. J., Gottlieb, L. S., Sternberg, S. S., ... & National Polyp Study Workgroup. (1993). Prevention of colorectal cancer by colonoscopic polypectomy. New England Journal of Medicine, 329(27), 1977-1981.

Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021). ACG clinical guidelines: colorectal cancer screening 2021. Official journal of the American College of Gastroenterology| ACG, 116(3), 458-479.

Wolf, A. M., Fontham, E. T., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., ... & Smith, R. A. (2018). Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA: a cancer journal for clinicians, 68(4), 250-281.

Morgan, E., Arnold, M., Gini, A., Lorenzoni, V., Cabasag, C. J., Laversanne, M., ... & Bray, F. (2023). Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut, 72(2), 338-344.

Andersson, K. E., & Arner, A. (2004). Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiological reviews, 84(3), 935-986.

Wong, M. C., Fung, F. D., Leung, C., Cheung, W. W., Goggins, W. B., & Ng, C. F. (2018). The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Scientific reports, 8(1), 1129.

Edwards, T. J., Dickinson, A. J., Natale, S., Gosling, J., & McGrath, J. S. (2006). A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol‐driven haematuria clinic. BJU international, 97(2), 301-305.

Leal, J., Luengo-Fernandez, R., Sullivan, R., & Witjes, J. A. (2016). Economic burden of bladder cancer across the European Union. European urology, 69(3), 438-447.

Williams, P. F., Olsen, C. M., Hayward, N. K., & Whiteman, D. C. (2011). Melanocortin 1 receptor and risk of cutaneous melanoma: a meta‐analysis and estimates of population burden. International Journal of Cancer, 129(7), 1730-1740.

Seiberg, M. (2001). Keratinocyte–melanocyte interactions during melanosome transfer. Pigment Cell Research, 14(4), 236-242.

Morgan, A. M., Lo, J., & Fisher, D. E. (2013). How does pheomelanin synthesis contribute to melanomagenesis? Two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis. Bioessays, 35(8), 672-676.

Mitra, D., Luo, X., Morgan, A., Wang, J., Hoang, M. P., Lo, J., ... & Fisher, D. E. (2012). An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature, 491(7424), 449-453.

Premi S, Wallisch S, Manu CM, Weiner AB, Bacchiocchi A, Wakamatsu K, Bechara EJ, Halaban R, Douki T, Brash DE. 2015. Chemexcitation of melanin derivatives induces DNA photoproducts long after UV exposure.pdf. Science. 347(6224):842–847. doi: 10.1126/science.1256022.

Mary, A., Dayan, J., Leone, G., Postel, C., Fraisse, F., Malle, C., ... & Gagnepain, P. (2020). Resilience after trauma: The role of memory suppression. Science, 367(6479), eaay8477.

Berlanda, S. F., Breitfeld, M., Dietsche, C. L., & Dittrich, P. S. (2020). Recent advances in microfluidic technology for bioanalysis and diagnostics. Analytical chemistry, 93(1), 311-331.

Godswill, A. C., Amagwula, I. O., Igwe, V. S., & Gonzaga, A. I. (2018). Effects of repeated deep frying on refractive index and peroxide value of selected vegetable oils.

Awuchi, C. G., Amagwula, I. O., Priya, P., Kumar, R., Yezdani, U., & Khan, M. G. (2020). Aflatoxins in foods and feeds: A review on health implications, detection, and control. Bull. Environ. Pharmacol. Life Sci, 9, 149-155.

Kaur, R. P., Vasudeva, K., Kumar, R., & Munshi, A. (2018). Role of p53 gene in breast cancer: focus on mutation spectrum and therapeutic strategies. Current pharmaceutical design, 24(30), 3566-3575.

Kumar, R., Saha, P., Lokare, P., Datta, K., Selvakumar, P., & Chourasia, A. (2022). A Systemic Review of Ocimum sanctum (Tulsi): Morphological Characteristics, Phytoconstituents and Therapeutic Applications. International Journal for Research in Applied Sciences and Biotechnology, 9(2), 221-226.

Kumar, R., & Saha, P. (2022). A review on artificial intelligence and machine learning to improve cancer management and drug discovery. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 149-156.

Umama, Y., Venkatajah, G., Shourabh, R., Kumar, R., Verma, A., Kumar, A., & Gayoor, M. K. (2019). Topic-The scenario of pharmaceuticals and development of microwave as; sisted extraction technique. World J Pharm Pharm Sci, 8(7), 1260-1271.

Dubey, A., Yadav, P., Verma, P., & Kumar, R. (2022). Investigation of proapoptotic potential of ipomoea carnea leaf extract on breast cancer cell line. Journal of Drug Delivery and Therapeutics, 12(1), 51-55.

Bind, A., Das, S., Singh, V. D., Kumar, R., Chourasia, A., & Saha, P. (2020). Natural Bioactives For The Potential Management Of Gastric Ulceration. Turkish Journal of Physiotherapy and Rehabilitation, 32(3), 221-226.

Kumar, R., Sood, U., Gupta, V., Singh, M., Scaria, J., & Lal, R. (2020). Recent advancements in the development of modern probiotics for restoring human gut microbiome dysbiosis. Indian journal of microbiology, 60, 12-25.

Daharia, A., Jaiswal, V. K., Royal, K. P., Sharma, H., Joginath, A. K., Kumar, R., & Saha, P. (2022). A Comparative review on ginger and garlic with their pharmacological Action. Asian Journal of Pharmaceutical Research and Development, 10(3), 65-69.

Saha, P., Kumar, R., Nyarko, R. O., Kahwa, I., & Owusu, P. (2021). Herbal Secondary Metabolite For Gastro-Protective Ulcer Activity With Api Structures.

Kumar, R., Saha, P., Kumar, Y., Sahana, S., Dubey, A., & Prakash, O. (2020). A Review on Diabetes Mellitus: Type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences, 9(10), 838-850.

Roshan, K. (2020). Priya damwani, Shivam kumar, Adarsh suman, Suthar Usha. An overview on health benefits and risk factor associated with coffee. International Journal Research and Analytical Review, 7(2), 237-249.

Kumar, R., Saha, P., Nyarko, R. O., Kahwn, I., Boateng, E. A., Boateng, P. O., ... & Bertram, A. (2021). Role of Cytokines and Vaccines in Break through COVID 19 Infections. Journal of Pharmaceutical Research International, 33(60B), 2544-2549.

Saha, P. (2020). Evolution of tolbutamide in the treatment of diabetes mellitus. Diabetes, 2(10).

Nyarko, R. O., Prakash, A., Kumar, N., Saha, P., & Kumar, R. (2021). Tuberculosis a globalized disease. Asian Journal of Pharmaceutical Research and Development, 9(1), 198-201.

Sahana, S. (2020). Purabi saha, Roshan kumar, Pradipta das, Indranil Chatterjee, Prasit Roy, Sk Abdur Rahamat. A Review of the 2019 Corona virus (COVID-19) World Journal of Pharmacy and Pharmaceutical science, 9(9), 2367-2381.

Saha, P., Nyarko, R. O., Lokare, P., Kahwa, I., Boateng, P. O., & Asum, C. (2022). Effect of Covid-19 in Management of Lung Cancer Disease: A Review. Asian Journal of Pharmaceutical Research and Development, 10(3), 58-64.

Nyarko, R. O., Kumar, R., Sharma, S., Chourasia, A., Roy, A., & Saha, P. (2022). Antibacterial Activity of Herbal Plant-Tinospora Cordifolia And Catharnthus Roseus.

Raj, A. R. J. E. S. H., Tyagi, S., Kumar, R., Dubey, A., & Hourasia, A. C. (2021). Effect of isoproterenol and thyroxine in herbal drug used as cardiac hypertrophy. Journal of Cardiovascular Disease Research, 204-217.

Kumar, R., Verma, H., Singhvi, N., Sood, U., Gupta, V., Singh, M., ... & Lal, R. (2020). Comparative genomic analysis of rapidly evolving SARS-CoV-2 reveals mosaic pattern of phylogeographical distribution. Msystems, 5(4), e00505-20.

Talwar, C., Nagar, S., Kumar, R., Scaria, J., Lal, R., & Negi, R. K. (2020). Defining the environmental adaptations of genus Devosia: insights into its expansive short peptide transport system and positively selected genes. Scientific reports, 10(1), 1151.

Sahana, S. (2020). Roshan kumar, Sourav nag, Reshmi paul, Nilayan guha, Indranil Chatterjee. A Review on Alzheimer disease and future prospects. World Journal of Pharmacy and Pharmaceutical science, 9(9), 1276-1285.

Nyarko, R. O., Boateng, E., Kahwa, I., Boateng, P. O., & Asare, B. (2020). The impact on public health and economy using lockdown as a tool against COVID-19 pandemic in Africa: a perspective. J Epidemiol Public Health Rev, 5(3).

Kumar, R., & Dubey, A. (2020). Phytochemical Investication And Heptoprotective Evalution Acacia Rubica Extract Isonized And Paracetamol Indused Animal Toxicity. Turkish Journal of Physiotherapy and Rehabilitation, 32(3), 65-69.

Purabisaha, R. K., Rawat, S. S. N., & Prakash, A. (2021). A Review On Novel Drug Delivery System.

Kumar, R., Saha, P., Sarkar, S., Rawat, N., & Prakash, A. (2021). A Review On Novel Drug Delivery System. IJRAR-International Journal of Research and Analytical Reviews (IJRAR), 8(1), 183-199.

Kumar, R., Jain, A., Tripathi, A. K., & Tyagi, S. (2021, January). Covid-19 outbreak: An epidemic analysis using time series prediction model. In 2021 11th international conference on cloud computing, data science & engineering (Confluence) (pp. 1090-1094). IEEE.

Nyarko, R. O., Boateng, E., Kahwa, I., & Boateng, P. O. (2020). A comparison analysis on remdesivir, favipiravir, hydroxychloroquine, chloroquine and azithromycin in the treatment of corona virus disease 2019 (COVID-19)-A Review. World J. Pharm. Pharm. Sci, 9, 121-133.

Sahana, S., Kumar, R., Nag, S., Paul, R., Chatterjee, I., & Guha, N. (2020). A Review On Alzheimer Disease And Future Prospects.

Kumar, A. (2019). The Scenario of Pharmaceuticals and Development of Microwave Assisted Extraction Techniques.

Saha, P., Kumar, A., Bhanja, J., Shaik, R., Kawale, A. L., & Kumar, R. (2022). A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 201-209.

Nalimu, F., Oloro, J., Kahwa, I., & Ogwang, P. E. (2021). Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences, 7, 1-21.

Bugga, P., Alam, M. J., Kumar, R., Pal, S., Chattopadyay, N., & Banerjee, S. K. (2022). Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast. Cellular Signalling, 94, 110309.

SHAFQAT ZAIDI, R. K. M., TYAGI, S., & Dubey, R. K. A. (2021). Effect of Kalahari Cactus Extract on Appetitte, Body Weight And Lipid Profile In Cafeteria Diet Induced Obesity In Experimental Animal. Annals of the Romanian Society for Cell Biology, 25(6), 13976-13987.

Singh, Y., Paswan, S. K., Kumar, R., Otia, M. K., Acharya, S., Kumar, D., & Keshamma, E. (2022). Plant & Its Derivative Shows Therapeutic Activity on Neuroprotective Effect. Journal for Research in Applied Sciences and Biotechnology, 1(2), 10-24.

Kumar, N., Dubey, A., Mishra, A., & Tiwari, P. (2020). Ethosomes: A Novel Approach in Transdermal Drug Delivery System. International journal of pharmacy & life sciences, 11(5).

Kumar, R., Saha, P., Keshamma, E., Sachitanadam, P., & Subramanian, M. (2022). Docking studies of some novel Hetrocyclic compound as Acat inhibitors: A meta analysis. Journal for Research in Applied Sciences and Biotechnology, 1(3), 33-41.

Nyarko, R. O., Roopini, R., Raviteja, V., Awuchi, C. G., Kumar, R., Faller, E. M., ... & Saha, P. (2022). Novel Sars-CoV-2 Variants & Therapeutic Effects. Journal for Research in Applied Sciences and Biotechnology, 1(2), 25-34.

Robles-espinoza CD, Roberts ND, Chen S, Leacy FP, Alexandrov LB, Pornputtapong N, Halaban R, Krauthammer M, Cui R, Bishop DT, et al. 2016. Germline MC1R status influences somatic mutation burden in melanoma. Nat Commun. 7(May):1–7. doi: 10.1038/ncomms12064.

Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007). Melanoma biology and new targeted therapy. Nature, 445(7130), 851-857.

Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., ... & Campbell, P. J. (2015). High burden and pervasive positive selection of somatic mutations in normal human skin. Science, 348(6237), 880-886.

D’Orazio, J. A., Marsch, A., & Veith, J. L. W. B. (2011). Skin pigmentation and melanoma risk. Advances in malignant melanoma-clinical research perspective, 39-68.

Shain, A. H., Joseph, N. M., Yu, R., Benhamida, J., Liu, S., Prow, T., ... & Bastian, B. C. (2018). Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution. Cancer cell, 34(1), 45-55.

Rebecca, V. W., Sondak, V. K., & Smalley, K. S. (2012). A brief history of melanoma: from mummies to mutations. Melanoma research, 22(2), 114.

Byrd, D. R., Brookland, R. K., Washington, M. K., Gershenwald, J. E., Compton, C. C., Hess, K. R., ... & Meyer, L. R. (2017). AJCC cancer staging manual (Vol. 1024). M. B. Amin, S. B. Edge, & F. L. Greene (Eds.). New York: springer.

Zincke, H., Bergstralh, E. J., Blute, M. L., Myers, R. P., Barrett, D. M., Lieber, M. M., ... & Oesterling, J. E. (1994). Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. Journal of Clinical Oncology, 12(11), 2254-2263.

Fall, K., Garmo, H., Andrén, O., Bill-Axelson, A., Adolfsson, J., Adami, H. O., ... & Holmberg, L. (2007). Prostate-specific antigen levels as a predictor of lethal prostate cancer. Journal of the National Cancer Institute, 99(7), 526-532.

Parekh, D. J., Ankerst, D. P., & Thompson, I. M. (2007). Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies. Journal of the National Cancer Institute, 99(7), 496-497.

Mason, M. D., Sydes, M. R., Glaholm, J., Langley, R. E., Huddart, R. A., Sokal, M., ... & Dearnaley, D. P. (2007). Oral sodium clodronate for nonmetastatic prostate cancer—results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873). Journal of the National Cancer Institute, 99(10), 765-776.

Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J., Jones, G. W., ... & Warner, J. (1994). Results of conservative management of clinically localized prostate cancer. New England Journal of Medicine, 330(4), 242-248.

Shappley III, W. V., Kenfield, S. A., Kasperzyk, J. L., Qiu, W., Stampfer, M. J., Sanda, M. G., & Chan, J. M. (2009). Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. Journal of Clinical Oncology, 27(30), 4980.

Ilic, M., & Ilic, I. (2016). Epidemiology of pancreatic cancer. World journal of gastroenterology, 22(44), 9694.

Wong, M. C., Jiang, J. Y., Liang, M., Fang, Y., Yeung, M. S., & Sung, J. J. (2017). Global temporal patterns of pancreatic cancer and association with socioeconomic development. Scientific reports, 7(1), 3165.

Saad, A. M., Turk, T., Al-Husseini, M. J., & Abdel-Rahman, O. (2018). Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC cancer, 18(1), 1-11.

Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer statistics, 2017. Ca Cancer J Clin, 67(1), 7-30.

Capurso, G., & Sette, C. (2019). Drug resistance in pancreatic cancer: New player caught in act. EBioMedicine, 40, 39-40.

Ni, L., Tao, J., Xu, J., Yuan, X., Long, Y., Yu, N., ... & Zhang, Y. (2020). Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis. Archives of gynecology and obstetrics, 301, 251-261.

Brinton, L. A., Felix, A. S., McMeekin, D. S., Creasman, W. T., Sherman, M. E., Mutch, D., ... & Zaino, R. (2013). Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecologic oncology, 129(2), 277-284.

Conlon, N., Leitao Jr, M. M., Abu-Rustum, N. R., & Soslow, R. A. (2014). Grading uterine endometrioid carcinoma: a proposal that binary is best. The American journal of surgical pathology, 38(12), 1583-1587.

Altman, A. D., Ferguson, S. E., Atenafu, E. G., Köbel, M., McAlpine, J. N., Panzarella, T., ... & Bernardini, M. Q. (2015). Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers. Gynecologic oncology, 139(2), 268-274.

Casey, M. J., Bewtra, C., Lynch, H. T., Snyder, C. L., & Stacey, M. (2015). Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications. International Journal of Gynecologic Cancer, 25(4).

Zhao, Y., Zou, X., Wang, G., Liu, Y., Zhang, C., Lu, W., & Li, Q. (2021). Effects of GATA6-AS/MMP9 on malignant progression of endometrial carcinoma. Journal of the Balkan Union of Oncology, 26(5), 1789-1795.

Lax, S. F., Kurman, R. J., Pizer, E. S., Wu, L., & Ronnett, B. M. (2000). A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. The American journal of surgical pathology, 24(9), 1201-1208.

Cooper, D. S. (2009). American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-1214.

Corso, C., Gomez, X., Sanabria, A., Vega, V., Dominguez, L. C., & Osorio, C. (2014). Total thyroidectomy versus hemithyroidectomy for patients with follicular neoplasm. A cost-utility analysis. International Journal of Surgery, 12(8), 837-842.

Welker MJ, Orlov D. Thyroid nodules. Am Fam Physician. 2003; 67: 559–566.

Sankaranarayanan, R., Ramadas, K., Amarasinghe, H., Subramanian, S., & Johnson, N. (2015). Oral cancer: prevention, early detection, and treatment. Cancer: disease control priorities, third edition (volume 3).

Brown, L. M., Check, D. P., & Devesa, S. S. (2011). Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes & Control, 22, 753-763.

Chainani-Wu, N., Epstein, J., & Touger-Decker, R. (2011). Diet and prevention of oral cancer: strategies for clinical practice. The Journal of the American Dental Association, 142(2), 166-169.

Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B., ... & Fu, K. K. (2004). Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 350(19), 1937-1944.

Dedhia, R. C., Smith, K. J., Johnson, J. T., & Roberts, M. (2011). The cost‐effectiveness of community‐based screening for oral cancer in high‐risk males in the United States: a Markov decision analysis approach. The Laryngoscope, 121(5), 952-960.

Deneo–Pellegrini, H., De Stefani, E., Boffetta, P., Ronco, A. L., Acosta, G., Correa, P., & Mendilaharsu, M. (2013). Maté consumption and risk of oral cancer: Case‐control study in Uruguay. Head & neck, 35(8), 1091-1095.

Downer, M. C., Moles, D. R., Palmer, S., & Speight, P. M. (2004). A systematic review of test performance in screening for oral cancer and precancer. Oral oncology, 40(3), 264-273.

Edwards, P. C. (2013). Oral cancer screening for asymptomatic adults: do the United States Preventive Services Task Force draft guidelines miss the proverbial forest for the trees?. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116(2), 131-134.